NewsFeed Voices Science Insight Innovation
December, 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Michael Makris Invites You to The Research Recap on FEIBA Use in Patients on Emicizumab
Michael Makris/LinkedIn
Oct 16, 2025, 04:43

Michael Makris Invites You to The Research Recap on FEIBA Use in Patients on Emicizumab

Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, Editor-in-Chief of RPTH Journal, reposted from ISTH on LinkedIn:

”If you treat persons with haemophilia and inhibitors, or if you are affected by the disease, we have a research recap that you may be interested in.

It relates to a paper and commentary published in the RPTH Journal on the use of FEIBA in patients on emicizumab (Hemlibra).

It will be interesting to discuss the issue with Drs Sidonio and Hermans.

Please join us next Tuesday at 11:15 ET, 16:15 UK and 17:15 Europe time.”

Quoting International Society on Thrombosis and Haemostasis( ISTH)‘s post:

”New RPTH Journal Research Recap! Dive into the latest insights from the article:
“Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.”

Join Robert Sidonio and Cedric Hermans (Lon,Edin) for an engaging discussion led by Michael Makris RPTH Editor-in-Chief.

Discover how emerging evidence is shaping clinical practice.

Don’t miss this expert-driven conversation!

Read ahead:

Register here.

This Research Recap is supported by an educational grant from TAKEDA PHARMACEUTICALS AMERICA, INC.”

Michael Makris Invites You to The Research Recap on FEIBA Use in Patients on Emicizumab

Stay updated with Hemostasis Today.

bleeding disorders Cedric Hermans Emicizumab emostasis Today FEIBA Headlines Health Hematology Hemlibra Hemophilia Hemostasis ISTH Medicine Michael Makris Research Recap Robert Sidonio rpth Takeda University of Sheffield
NewsFeed